These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16781706)

  • 21. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
    Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
    Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis.
    Andreassen OA; Dedeoglu A; Klivenyi P; Beal MF; Bush AI
    Neuroreport; 2000 Aug; 11(11):2491-3. PubMed ID: 10943709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal methods to characterize the G93A mouse model of ALS.
    Miana-Mena FJ; Muñoz MJ; Yagüe G; Mendez M; Moreno M; Ciriza J; Zaragoza P; Osta R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):55-62. PubMed ID: 16036427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
    Yao BB; Mukherjee S; Fan Y; Garrison TR; Daza AV; Grayson GK; Hooker BA; Dart MJ; Sullivan JP; Meyer MD
    Br J Pharmacol; 2006 Sep; 149(2):145-54. PubMed ID: 16894349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice.
    Choi CI; Lee YD; Gwag BJ; Cho SI; Kim SS; Suh-Kim H
    J Neurol Sci; 2008 May; 268(1-2):40-7. PubMed ID: 18054961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
    Weydt P; Hong S; Witting A; Möller T; Stella N; Kliot M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):182-4. PubMed ID: 16183560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
    Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of the CB
    Rodríguez-Cueto C; Gómez-Almería M; García Toscano L; Romero J; Hillard CJ; de Lago E; Fernández-Ruiz J
    Brain Pathol; 2021 Nov; 31(6):e12972. PubMed ID: 33983653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
    Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
    Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
    Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyotrophic lateral sclerosis (ALS) and extremely-low frequency (ELF) magnetic fields: a study in the SOD-1 transgenic mouse model.
    Poulletier de Gannes F; Ruffié G; Taxile M; Ladevèze E; Hurtier A; Haro E; Duleu S; Charlet de Sauvage R; Billaudel B; Geffard M; Veyret B; Lagroye I
    Amyotroph Lateral Scler; 2009; 10(5-6):370-3. PubMed ID: 19922126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis.
    Avraham HK; Jiang S; Fu Y; Rockenstein E; Makriyannis A; Zvonok A; Masliah E; Avraham S
    Br J Pharmacol; 2014 Jan; 171(2):468-79. PubMed ID: 24148086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway.
    Wu Y; Ma R; Long C; Shu Y; He P; Zhou Y; Xiang Y; Wang Y
    Int J Immunopathol Pharmacol; 2021; 35():20587384211035251. PubMed ID: 34384259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
    Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y
    PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
    Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.